The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Biocartis; Chrysalis Biomedical Advisors; COMM Santé; Lilly; Pierre Fabre; Sanofi; SERVIER; SERVIER
Atezolizumab plus modified DCF (docetaxel, cisplatin, and 5-fluorouracil) as first-line treatment for metastatic or locally advanced squamous cell anal carcinoma: A SCARCE-PRODIGE 60 randomized phase II study.
 
Stefano Kim
Consulting or Advisory Role - BeiGene; Boehringer Ingelheim; Ipsen
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Pfizer; Roche; Sanofi
 
François Ghiringhelli
Honoraria - roche
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Roche/Genentech; Roche/Genentech
 
Christelle De La Fouchardiere
Honoraria - Merck Serono; Merck Serono; Roche; Roche
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; Lilly; MSD Oncology; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Ipsen
Research Funding - Pierre Fabre (Inst); Roche; Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Bristol-Myers Squibb; Celgene; Roche; Roche; Roche; SERVIER
Other Relationship - Incyte; MSD Oncology
 
Eric FRANCOIS
Honoraria - Amgen; Pierre Fabre; Viatris
Consulting or Advisory Role - Pierre Fabre
Travel, Accommodations, Expenses - Roche; SERVIER
 
Denis Michel Smith
No Relationships to Disclose
 
Emmanuelle Samalin
Consulting or Advisory Role - MSD Oncology (Inst); Pierre Fabre; SERVIER
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Merck Serono; Pierre Fabre; SERVIER
 
Daniel Lopez-Trabada Ataz
Expert Testimony - Servier
 
Aurélie Parzy
No Relationships to Disclose
 
Jérôme Desrame
Expert Testimony - Roche
Travel, Accommodations, Expenses - Hospira
 
Nabil Baba-Hamed
No Relationships to Disclose
 
Bruno Buecher
No Relationships to Disclose
 
David Tougeron
Honoraria - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD; Roche; Sanofi; Servier/Pfizer
Consulting or Advisory Role - AstraZeneca; MSD; Pierre Fabre; Sanofi
Research Funding - AstraZeneca (Inst); BTG (Inst); MSD (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Sanofi
 
Olivier Bouché
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Amgen; Bayer; Merck Serono; Pierre Fabre; Sanofi; Servier
 
Benoist Chibaudel
No Relationships to Disclose
 
Farid El Hajbi
No Relationships to Disclose
 
Marie-Line Garcia-Larnicol
No Relationships to Disclose
 
Aurelia Meurisse
No Relationships to Disclose
 
Dewi Vernerey
Consulting or Advisory Role - AC BioScience; CellProthera; Fondazione Smith Kline; GERCOR; HalioDx; INCYTE; INVECTYS; Janssen-Cilag; OSE Immunotherapeutics; Pfizer
Travel, Accommodations, Expenses - MSD
 
Simon Pernot
No Relationships to Disclose
 
Christophe Borg
Consulting or Advisory Role - Bayer; MSD Oncology; Pierre Fabre; Roche/Genentech
Research Funding - Roche/Genentech (Inst)